EAM
DMTK

Exos Asset Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Exos Asset Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,760
Closed -$364K – 746
2021
Q2 		$364K Sell
8,760
-1,173
-12% -$48.2K 0.19% 158
2021
Q1 		$504K Buy
+9,933
New +$520K 0.4% 95

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return

Exos Asset Management's DMTK Position: Q3 2021 in Review

Exos Asset Management sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2021, closing a stake of 8,760 shares — an estimated $364K sold.

Exos Asset Management first reported a position in DMTK in Q1 2021 and held it in 2 quarters. The position peaked at $504K in Q1 2021. 162 funds tracked by Wall St. Rank hold DMTK as of Q3 2021.

  • Exos Asset Management reported no remaining DermTech, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Exos Asset Management sold 8,760 DermTech, Inc. Common Stock shares in Q3 2021, an estimated $364K.
  • Exos Asset Management first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Exos Asset Management's DermTech, Inc. Common Stock position peaked at $504K in Q1 2021.
  • 162 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2021.

Based on Exos Asset Management's 13F filing for Q3 2021, filed 25 Oct 2021.